Home example 2 - Pharmamarketeer

onderzoek

Time to Results Faster With Point-of-Care COVID-19 Testing

COVID-19 testing THURSDAY, Oct. 15, 2020 — Point-of-care testing is associated with large reductions in the time to results for patients presenting with suspected COVID-19, according to a study published online...

Drugs.com: Drug Information Online

3 x gelezen

marketing

Hoe kan jij creatief denken met online marketing?

Online marketing Een eigen bedrijf hebben is voor veel ondernemers een echte hobby wat veranderd is in werk. Sommige ondernemers zeggen dat ze nooit meer werken sinds zij een eigen bedrijf zijn begonnen. En vaak is dat...

fonkonline.nl

3 x gelezen

overig

5 brands share their content marketing process

It’s a hazard of the job for content marketers. When you read or see a piece of high-quality content, you wonder how it got created. You ask yourself, “What does this company do to create great content? Is it great for...

contentmarketinginstitute.com

3 x gelezen

wet- en regelgeving

FDA approves Pfizer’s drug for advanced breast cancer

The U.S. Food and Drug Administration said on Tuesday it approved Pfizer Inc’s drug for an advanced form of breast cancer tied to an inherited gene mutation.

Reuters Health

3 x gelezen

farma-industrie

Pfizer and Novartis partner up to develop combo therapies for NASH

Pfizer and Novartis are set to team up in a non-exclusive partnership aimed at the clinical development of one or more combo therapies for the treatment of non-alcoholic steatohepatitis (NASH). Under the partnership...

InPharm.com

3 x gelezen

wet- en regelgeving

Keytruda Gets FDA Approval for Hepatocellular Carcinoma

The approval was based on data from the KEYNOTE-224 study, a single-arm trial in patients with HCC who had disease progression on or after sorafenib or were intolerant to sorafenib; had measurable disease; and Child...

Monthly Prescribing Reference (MPR): Drug News

3 x gelezen

onderzoek

Phase 3 failure of asthma therapy sends Vectura’s ailing shares falling

Vectura has announced it is terminating development of its severe asthma therapy VR475, an inhaled formulation of the corticosteroid budesonide, after it failed in Phase 3 trials to demonstrate a significant impact on...

InPharm.com

3 x gelezen

farma-industrie

Roche’s Hemlibra stakes claim to be haemophilia market leader

Hemlibra was widely expected to become the dominant therapeutic for treating haemophilia patients and its latest clinical trial results only cements its prospects in the field.

Pharmafile

3 x gelezen

farma-industrie

J&J stock tumbles after Reuters reports it hid asbestos in talc

After a series of ups and downs in defense of its flagship Johnson’s Baby Powder, Johnson & Johnson hit renewed scrutiny Friday as Reuters reported the drugmaker knew for decades its powder contained cancer-causing...

FiercePharma

3 x gelezen

marketing

The Weekly Wrap: Data Makes Content Marketing Better

In less time than it takes the Kardashians to pick a fight, Robert Rose dishes all about data this week. He reveals a tactic missed by many, converses with a Content Marketer of the Year finalist, and shares a content...

Content Marketing Institute

3 x gelezen

Latest articles

Time to Results Faster With Point-of-Care COVID-19 Testing

Hoe kan jij creatief denken met online marketing?

5 brands share their content marketing process

FDA approves Pfizer’s drug for advanced breast cancer

Pfizer and Novartis partner up to develop combo therapies for NASH

Keytruda Gets FDA Approval for Hepatocellular Carcinoma

Phase 3 failure of asthma therapy sends Vectura’s ailing shares falling

Roche’s Hemlibra stakes claim to be haemophilia market leader

J&J stock tumbles after Reuters reports it hid asbestos in talc

The Weekly Wrap: Data Makes Content Marketing Better

Wekelijkse highlights per e-mail

Algemene informatie